menu search

Editas Medicine Announces Second Quarter 2023 Results Conference Call and Corporate Update

Editas Medicine Announces Second Quarter 2023 Results Conference Call and Corporate Update
CAMBRIDGE, Mass., July 26, 2023 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage genome editing company, today announced that it will host a conference call and webcast on Wednesday, August 2, 2023, at 8:00 a.m. ET to discuss results for the second quarter 2023 and to provide a corporate update. To access the conference call: U.S. […] The post Editas Medicine Announces Second Quarter 2023 Results Conference Call and Corporate Update appeared first on ForexTV... Read More
Posted: Jul 26 2023, 11:00
Author Name: forextv
Views: 080831

Search within

Pages Search Results: